ArticleHaematologica2026

Proteomic shifts post-plasma cell therapy in AL amyloid plaques and potential implications for light chaindirected anti-fibril monoclonal antibodies.

Matthew J Rees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.